Sarclisa OverviewIsatuximab, sold under the brand name Sarclisa, is a monoclonal antibody (mAb) medication for the treatment of multiple myeloma. The most common side effects include neutropenia (low levels of neutrophils, a type of white blood cell), infusion reactions, pneumonia (infection of the lungs), upper respiratory tract infection (such as nose and throat infections), diarrhoea and bronchitis (inflammation of the airways in the lungs). Isatuxim...
Read more Sarclisa Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Isatuximab
Recent Sarclisa Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 100mg/5ml (20mg/ml), 500mg/25ml (20mg/ml)
NDC Database Records for Sarclisa: (2 results)Sorted by National Drug Code
- 0024-0654 Sarclisa 100 mg/5ml Intravenous Injection, Solution, Concentrate by Sanof-aventis U.S. LLC
- 0024-0656 Sarclisa 500 mg/25ml Intravenous Injection, Solution, Concentrate by Sanof-aventis U.S. LLC